High severity · published Dec 4, 2025
CVE-2023-53734
dawa-pharma-1.0 - SQL Injection via Email Parameter
8.7
CVSS
0.5%
EPSS
No
On KEV
Description
dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.
Exploitation
Is it being used?
Exploit prediction (EPSS)0.5% · higher than 45% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
DA
dawa-pharma · mayurik
1.0-2022 · source: vendor
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2023-53734
CVE.org
https://www.cve.org/CVERecord?id=CVE-2023-53734
github.com
https://github.com/nu11secur1ty/CVE-nu11secur1ty/tree/main/vendors/mayuri_k/2022/dawa-pharma-1.0-2022
www.exploit-db.com
https://www.exploit-db.com/exploits/51818
www.mayurik.com
https://www.mayurik.com/source-code/P0349/best-pharmacy-billing-software-free-download
www.nu11secur1ty.com
https://www.nu11secur1ty.com/
www.vulncheck.com
https://www.vulncheck.com/advisories/dawa-pharma-10-sql-injection-via-email-parameter